Chia-Jui Yen

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Vascular Endothelial Growth Factor

Top Venues

Expert opinion on drug safety

Clinical cancer research : an official journal of the American Association for Cancer Research

Targeted oncology

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Petros D Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal, James J Harding, Elizabeth C Dees, Rastislav Bahleda, Nilofer S Azad, Asha Karippot, Razelle Kurzrock, Josep Tabernero, Juha Kononen, Matthew Chau Hsien Ng, Rutika Mehta, Nataliya V Uboha, Frédéric Bigot, Valentina Boni, Samantha E Bowyer, Valeriy Breder, Andres Cervantes, Nancy Chan, James M Cleary, Mallika Dhawan, Rikke Helene Løvendahl Eefsen, James Ewing, Donna M Graham, Tormod Kyrre Guren, Jin Won Kim, Krassimir Koynov, Do Youn Oh, Rebecca A Redman, Chia-Jui Yen, David B Spetzler, Marie-Claude Roubaudi-Fraschini, Valérie Nicolas, Rafik Ait-Sarkouh, Claudio Zanna, Abdallah Ennaji, Anna Pokorska-Bocci, Keith T Flaherty
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jiunn-Min Shieh, Ting-Wei Chang, Jing-He Wang, Song-Ping Liang, Pei-Lu Kao, Liang-Yi Chen, Chia-Jui Yen, Yun-Ju Chen, Wen-Chang Chang, Ben-Kuen Chen
RNA-binding protein-regulated fibronectin is essential for EGFR-activated metastasis of head and neck squamous cell carcinoma. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (10) (2023)
Chih-Chieh Yen, Yu-Min Yeh, Hsuan-Yi Huang, Yu-Lin Ting, Pei-An Fu, Tzu-Chien Lin, I-Ting Liu, Chia-Jui Yen
Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours. Targeted oncology (2023)
Chih-Chieh Yen, Chia-Jui Yen
Safety of ramucirumab treatment in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein. Expert opinion on drug safety (2021)